ARAP1 and breast carcinoma: ARAP1-AS1 is overexpressed in breast cancer cells and ARAP1-AS1 silencing results in inhibited proliferation, blocked migration, and strengthened apoptosis of breast cancer cells via the microRNA-2110/histone deacetylase 2/perilipin 1 axis [37].